Chad Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Chad Therapeutics, Inc. holds 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 25 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include BONSAI, OXYFILL, and OXYMIZER. The owner is based in CHATSWORTH, CA.
21622 PLUMMER STREET
CHATSWORTH, CA 91311
Showing of trademarks Trademarks
Trademark Classifications
Chad Therapeutics, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Chad Therapeutics, Inc. have?
Chad Therapeutics, Inc. has 25 U.S. trademarks filed with the USPTO. Of these, 3 registered, 13 abandoned, 9 cancelled.
What trademark classes does Chad Therapeutics, Inc. file in?
Chad Therapeutics, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Chad Therapeutics, Inc.'s most well-known trademarks?
Chad Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as BONSAI, OXYFILL, and OXYMIZER. These are among 3 currently registered trademarks in the portfolio.
What is Chad Therapeutics, Inc.'s trademark registration success rate?
Chad Therapeutics, Inc. has a 12% trademark registration rate, with 3 out of 25 resolved applications resulting in successful registration. Currently, 0 applications are pending review.